NCT06331598 2024-12-24
IMperator
Hoffmann-La Roche
Phase 2 Withdrawn
Clinical Trials
8 trialsNCT05231733 2024-10-31
Study of SPX-101 in Subjects With Advanced or Refractory Solid Tumors
SparX Biotech(Jiangsu) Co., Ltd.
Phase 1 Withdrawn
NCT05644626 2023-11-29
Safety, Pharmacokinetics and Antitumor Activity of BGB-B167 Alone and in Combination With Tislelizumab in Participants With Solid Tumors in Chinese Participants
BeiGene
Phase 1 Withdrawn
NCT02845414 2018-10-03
Study of CD133KDEL Toxin in the Treatment for Solid Tumors
Masonic Cancer Center, University of Minnesota
Phase 1 Withdrawn
NCT01245543 2015-11-02
Safety Study for Intravenous (IV) AC480 (AC480IV) to Treat Advanced Solid Tumors
Daiichi Sankyo
Phase 1 Withdrawn
NCT02120118 2015-06-09
Combination of Hyperthermia and Concurrent Chemoradiotherapy (CCRT) in Treatment Failure Solid Tumors
Shin Kong Wu Ho-Su Memorial Hospital
Phase 2 Withdrawn
NCT01940601 2015-01-14
Pharmacodynamics, Pharmacokinetics, Efficacy and Safety of Balugrastim in Pediatric Patients With Solid Tumors
Teva Branded Pharmaceutical Products R&D, Inc.
Phase 2 Withdrawn
NCT00754104 2011-01-19
Study of ABT-869 in Combination With Tarceva in Subjects With Solid Tumors
Abbott
Phase 1 Withdrawn